Cornelissen J J, Maassen K, van Emst L, Weers P M, Harmsen M, Benaissa-Trouw B J, Oosterlaken T A, Kraaijeveld C A, Verhoef J
Department of Haematology, University Hospital Utrecht, The Netherlands.
Immunology. 1993 Aug;79(4):673-80.
Against lipid A (the conserved moiety of lipopolysaccharides from Gram-negative bacteria) neutralizing IgM monoclonal antibodies (mAb) 8-2 and 26-20 anti-idiotypic (Ab2) mAb were produced: Ab2 mAb KM-04 (IgG1) against mAb 8-2, and Ab2 mAb PW-1 (IgG2a) and PW-2 (IgG1) against mAb 26-20. The binding of Ab2 mAb KM-04 to 8-2 (Ab1) was strongly inhibited by a lipopolysaccharide (LPS) extract from either Salmonella minnesota R595 (Re LPS) or Escherichia coli J5 (Rc LPS), whereas the binding of Ab2 mAb PW-1 and PW-2 to 26-20 (Ab1) was only marginally inhibited by both Re LPS and Rc LPS. The results indicated that Ab2 mAb KM-04 recognizes a lipid A-binding site related idiotope on mAb 8-2 and therefore KM-04 might bear the internal image of a neutralization determining epitope of lipid A. Consequently Ab2 KM-04 might induce antibodies to lipid A. Indeed anti-idiotypic immunization of syngeneic BALB/c mice with Ab2 mAb KM-04 resulted in development of lipid A-binding anti-anti-idiotypic (Ab3) antibodies in serum. Similar immunizations with Ab2 mAb PW-1 and PW-2 were unsuccessful. However, induction of lipid A-binding Ab3 by mAb KM-04 proved to be genetically restricted to BALB/c mice. DBA/2 mice, Swiss mice and rabbits did not develop lipid A-binding antibodies upon immunization with mAb KM-04. In protection experiments, it was shown that BALB/c mice vaccinated with mAb KM-04 showed significantly enhanced survival from challenge with either rough (Re) LPS from Salmonella minnesota or smooth LPS from E. coli 0111:B4 when compared to BALB/c mice immunized with a non-relevant Ab2 mAb. The results suggest that mAb KM-04 constitutes a non-internal image vaccine to the lethal effect of lipid A in BALB/c mice. Furthermore an Ab3 mAb was prepared against Ab2 mAb KM-04 that showed reactivity with Re LPS. This Ab3 mAb, designated LE-21 (IgG2a) protected mice against an otherwise lethal challenge of Re LPS.
针对脂质A(革兰氏阴性菌脂多糖的保守部分),制备了中和性IgM单克隆抗体(mAb)8 - 2和抗独特型(Ab2)单克隆抗体26 - 20:针对mAb 8 - 2的Ab2单克隆抗体KM - 04(IgG1),以及针对mAb 26 - 20的Ab2单克隆抗体PW - 1(IgG2a)和PW - 2(IgG1)。Ab2单克隆抗体KM - 04与8 - 2(Ab1)的结合受到来自明尼苏达沙门氏菌R595(Re LPS)或大肠杆菌J5(Rc LPS)的脂多糖(LPS)提取物的强烈抑制,而Ab2单克隆抗体PW - 1和PW - 2与26 - 20(Ab1)的结合仅受到Re LPS和Rc LPS的轻微抑制。结果表明,Ab2单克隆抗体KM - 04识别mAb 8 - 2上与脂质A结合位点相关的独特型表位,因此KM - 04可能具有脂质A中和决定表位的内影像。因此,Ab2 KM - 04可能诱导产生针对脂质A的抗体。实际上,用Ab2单克隆抗体KM - 04对同基因BALB/c小鼠进行抗独特型免疫,导致血清中产生了结合脂质A的抗抗独特型(Ab3)抗体。用Ab2单克隆抗体PW - 1和PW - 2进行类似的免疫未成功。然而,事实证明,mAb KM - 04诱导产生结合脂质A 的Ab3具有遗传限制性,仅限于BALB/c小鼠。用mAb KM - 04免疫DBA/2小鼠、瑞士小鼠和兔子后,它们并未产生结合脂质A的抗体。在保护实验中,结果表明,与用无关Ab2单克隆抗体免疫的BALB/c小鼠相比,用mAb KM - 04接种的BALB/c小鼠在用来自明尼苏达沙门氏菌的粗糙(Re)LPS或来自大肠杆菌0111:B4的光滑LPS攻击后,存活率显著提高。结果表明,mAb KM - 04构成了一种针对BALB/c小鼠中脂质A致死效应的非内影像疫苗。此外还制备了一种针对Ab2单克隆抗体KM - 04的Ab3单克隆抗体,它与Re LPS有反应性。这种Ab3单克隆抗体命名为LE - 21(IgG2a),可保护小鼠免受Re LPS的致死性攻击。